171 related articles for article (PubMed ID: 38295969)
1. Ultrasound and magnetic resonance imaging-based investigation of the role of perfusion and oxygen availability in menstrual pain.
Cockrum RH; Tu FF; Kierzkowska O; Leloudas N; Pottumarthi PV; Hellman KM
Am J Obstet Gynecol; 2024 May; 230(5):553.e1-553.e14. PubMed ID: 38295969
[TBL] [Abstract][Full Text] [Related]
2. Abdominal skeletal muscle activity precedes spontaneous menstrual cramping pain in primary dysmenorrhea.
Oladosu FA; Tu FF; Farhan S; Garrison EF; Steiner ND; Roth GE; Hellman KM
Am J Obstet Gynecol; 2018 Jul; 219(1):91.e1-91.e7. PubMed ID: 29733841
[TBL] [Abstract][Full Text] [Related]
3. Cine MRI during spontaneous cramps in women with menstrual pain.
Hellman KM; Kuhn CS; Tu FF; Dillane KE; Shlobin NA; Senapati S; Zhou X; Li W; Prasad PV
Am J Obstet Gynecol; 2018 May; 218(5):506.e1-506.e8. PubMed ID: 29409786
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
Daniels S; Robbins J; West CR; Nemeth MA
Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
[TBL] [Abstract][Full Text] [Related]
5. The effect of nimesulide and naproxen on the uterine and ovarian arterial blood flow velocity. A Doppler study.
Pirhonen J; Pulkkinen M
Acta Obstet Gynecol Scand; 1995 Aug; 74(7):549-53. PubMed ID: 7618455
[TBL] [Abstract][Full Text] [Related]
6. Valdecoxib for treatment of primary dysmenorrhea. A randomized, double-blind comparison with placebo and naproxen.
Daniels SE; Torri S; Desjardins PJ
J Gen Intern Med; 2005 Jan; 20(1):62-7. PubMed ID: 15693930
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic Uterine Artery Occlusion Combined with Uterine-sparing Pelvic Plexus Block and Partial Adenomyomectomy for Adenomyosis: A Video Case Report.
Chen D; Ai G; Yang W; Liu J; Luo N; Guo J; Cheng Z
J Minim Invasive Gynecol; 2021 Oct; 28(10):1681-1684. PubMed ID: 34051355
[TBL] [Abstract][Full Text] [Related]
8. Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptoms.
Pinzauti S; Lazzeri L; Tosti C; Centini G; Orlandini C; Luisi S; Zupi E; Exacoustos C; Petraglia F
Ultrasound Obstet Gynecol; 2015 Dec; 46(6):730-6. PubMed ID: 25728241
[TBL] [Abstract][Full Text] [Related]
9. Effects of naproxen sodium on menstrual prostaglandins and primary dysmenorrhea.
Chan WY; Fuchs F; Powell AM
Obstet Gynecol; 1983 Mar; 61(3):285-91. PubMed ID: 6571974
[TBL] [Abstract][Full Text] [Related]
10. Low Serum Naproxen Concentrations Are Associated with Minimal Pain Relief: A Preliminary Study in Women with Dysmenorrhea.
Oladosu FA; Tu FF; Garrison EF; Dillane KE; Roth GE; Hellman KM
Pain Med; 2020 Nov; 21(11):3102-3108. PubMed ID: 32488234
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional power Doppler assessment of uterine vascularization in women with primary dysmenorrhea.
Royo P; Alcázar JL
J Ultrasound Med; 2008 Jul; 27(7):1003-10. PubMed ID: 18577663
[TBL] [Abstract][Full Text] [Related]
12. Cyclic changes in T2* relaxometry of human uterus during the menstrual cycle using BOLD MR imaging.
Li Y; Lai M; Li Q; Fu C; Zhang Q
Eur J Radiol; 2022 Nov; 156():110563. PubMed ID: 36272225
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy of Fructus agni casti in women with severe primary dysmenorrhea: a prospective comparative Doppler study.
Aksoy AN; Gözükara I; Kabil Kucur S
J Obstet Gynaecol Res; 2014 Mar; 40(3):779-84. PubMed ID: 24245554
[TBL] [Abstract][Full Text] [Related]
14. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
[TBL] [Abstract][Full Text] [Related]
15. Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia.
Rees MC; DiMarzo V; Tippins JR; Morris HR; Turnbull AC
J Endocrinol; 1987 May; 113(2):291-5. PubMed ID: 3035052
[TBL] [Abstract][Full Text] [Related]
16. Zinc treatment prevents dysmenorrhea.
Eby GA
Med Hypotheses; 2007; 69(2):297-301. PubMed ID: 17289285
[TBL] [Abstract][Full Text] [Related]
17. Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use.
Christelle K; Norhayati MN; Jaafar SH
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD006034. PubMed ID: 36017945
[TBL] [Abstract][Full Text] [Related]
18. Endometrial vascular development in heavy menstrual bleeding: altered spatio-temporal expression of endothelial cell markers and extracellular matrix components.
Biswas Shivhare S; Bulmer JN; Innes BA; Hapangama DK; Lash GE
Hum Reprod; 2018 Mar; 33(3):399-410. PubMed ID: 29309596
[TBL] [Abstract][Full Text] [Related]
19. Naproxen, paracetamol and pamabrom versus paracetamol, pyrilamine and pamabrom in primary dysmenorrhea: a randomized, double-blind clinical trial.
Ortiz MI; Murguía-Cánovas G; Vargas-López LC; Silva R; González-de la Parra M
Medwave; 2016 Oct; 16(9):e6587. PubMed ID: 27813503
[TBL] [Abstract][Full Text] [Related]
20. Anaprox in dysmenorrhea: reduction of pain and intrauterine pressure.
Henzl MR; Ortega-Herrera E; Rodriguez C; Izu A
Am J Obstet Gynecol; 1979 Oct; 135(4):455-60. PubMed ID: 484644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
